arrow
E

Eliza A. Hawkes

Florey Institute of Neuroscience and Mental Health
H指数:28
被引数:3,275

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma

LTB-TREAT:一种用于低肿瘤负荷滤泡性淋巴瘤治疗时间预测的国际验证性预后模型

2026-08-300
OAAI
End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study

治疗结束时的正电子发射断层扫描/计算机断层扫描完全缓解是结外周T细胞淋巴瘤的强预后指标:一项澳大拉西亚-加拿大合作研究

2026-08-210
PRE
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma

使用epcoritamab联合 bendamustine和rituximab的一线治疗在滤泡性淋巴瘤患者中诱导了超过3年的持续缓解

2026-08-050
OAAI
Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice

复发弥漫性大B细胞淋巴瘤注册试验中纳入标准的显著差异限制了其在临床实践中的适用性

2026-05-150
OAAI
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy

滤泡性淋巴瘤接受免疫化疗的治疗诊断至治疗间隔与结局相关

Blood
IF23.1
2026-04-160
PRE
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II ‘FLUORO’ study

检查点抑制剂、奥比妥珠单抗联合PET适应性超低剂量结内放射治疗对初治滤泡性淋巴瘤具有高疗效:来自II期“FLUORO”研究的结果

2026-04-080
OAAI
Meeting trial eligibility in Follicular lymphoma patients is associated with overall survival but not progression-free survival

滤泡性淋巴瘤患者满足临床试验入组标准与总生存期相关,但与无进展生存期无关。

2025-09-011
PRE
Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study

套细胞淋巴瘤(MCL)中的继发性中枢神经系统淋巴瘤(SCNSL):一项丹麦全国性人群为基础的研究中的特征与危险因素

2025-08-080
OAAI
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial

T细胞失调与B细胞淋巴瘤的放疗-免疫疗法反应:一项1期试验的结果

2025-06-260
OAAI
The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trial

PET/CT在外周T细胞淋巴瘤中的作用:来自英国NCRI第2阶段CHEMO-T试验PET/CT亚组研究的结果

2025-05-260
PRE
The 66th ASH Annual Meeting Abstracts

第66届ASH年会摘要

BLOOD
IF23.1
2024-11-050
PRE